Report Detail
High Potency Active Pharmaceutical Ingredients (HPAPI) Global Market – Forecast To 2023
- RnM3925062 |
- 12 March, 2020 |
- Global |
- 226 Pages |
- IQ4I Research & Consultancy |
- Other
The drugs are classified as High Potent if its Occupational Exposure Limit (OELs) ≤ 10µg/m3.The HPAPI global market is progressively increasing in terms of revenue and the rise in demand for outsourcing these intermediates, manufacturing is driven by expansion of oncology sector, which is the fastest among overall pharmaceutical sector.
The global HPAPI market is valued to be $XX million in 2016 and poised to grow at a CAGR of X% to reach $27,293.4 million by 2023. HPAPI market is mainly classified by customer base, by business type, by molecule type and Applications. The global HPAPI market is broadly classified as Innovative HPAPI and Generic HPAPI based on customer base. Based on business type, the market is classified into Captive HPAPI & Merchant HPAPI. HPAPI market is segmented on the basis of molecule type as Synthetic HPAPI and Biotech HPAPI. HPAPI market application segment is classified into Oncology, Cardiovascular, Central Nervous System, Hormonal, Glaucoma, Infectious, metabolic, Inflammation and other therapeutic applications.
Among Innovative & generic HPAPI, Innovative HPAPI occupies the major share in 2016 and generic HPAPIs expected to grow at a highest CAGR from 2016 to 2023. Among business type, Captive HPAPI occupies the major share of XX% in 2016 and Merchant HPAPI is expected to grow at a highest CAGR of X% from 2016 to 2023 to reach $XX million by 2023. Among molecule type, Synthetic HPAPI occupies the major share in 2016 and is expected to grow at a CAGR of X% from 2016 to 2023 to reach $XX million by 2023. Among Application segment, Oncology commanded the larger revenue of $XX million in 2016 and is expected to grow at a highest CAGR of X% from 2016 to 2023.
Increasing incidence of chronic and age related diseases, rapid growth in oncology market, growing demand for Antibody Drug Conjugates (ADC), technological advancements in HPAPI market, growing CMOs are some of the factors which are driving the market. Requirement of large investments, stringent safety and handling specifications associated with production of HPAPI, stringent regulations are the factors hindering the market.
North America accounts for the highest market share in 2016 and followed by Europe. However, Asian countries especially China and India are the fastest growing regions with its growing demand for HPAPIs. Asia-Pacific is projected to grow with a highest CAGR of XX% from 2016 to 2023.
Major players in HPAPI market include Alkermes plc (Ireland),Cambrex Corporation (U.S.),Dishman group (India), Dr. Reddy’s Laboratories (India), Lonza Group (Switzerland), Novasep (U.S.), Patheon N.V.( Netherland)(ThermoFisher Scientific), Pfizer (U.S.), Merck KGaA (Germany) and Teva Pharmaceutical Industries (Israel).
The report provides an in depth market analysis of the above mentioned segments across the following regions:
• North America
• Europe
• Asia-Pacific
• Rest of the World
1 EXECUTIVE SUMMARY 23
2 INTRODUCTION 28
- 2.1 KEY TAKE AWAYS 28
- 2.2 REPORT DESCRIPTION 29
- 2.3 MARKETS COVERED 30
- 2.4 STAKEHOLDERS 31
- 2.5 RESEARCH METHODOLOGY 32
- 2.5.1 MARKET SIZE ESTIMATION 33
- 2.5.2 MARKET BREAKDOWN AND DATA TRIANGULATION 36
- 2.5.3 SECONDARY SOURCES 37
- 2.5.4 PRIMARY SOURCES 38
- 2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES 38
- 2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES 39
- 2.5.7 ASSUMPTIONS 39
- 2.5.8 KEY CHARECTERISTICS OF HPAPI MANUFACTURING 41
3 MARKET ANALYSIS 42
- 3.1 INTRODUCTION 42
- 3.2 MARKET SEGMENTATION 43
- 3.3 FACTORS INFLUENCING MARKET 44
- 3.3.1 DRIVERS AND OPPORTUNITIES 45
- 3.3.1.1 Increasing incidence of chronic and age related diseases 45
- 3.3.1.2 Rapid growth in oncology market 45
- 3.3.1.3 Growing demand for Antibody Drug Conjugates (ADCs) 46
- 3.3.1.4 Technological advancements in HPAPI market 47
- 3.3.1.5 Growing CMOs (contract manufacturing organizations) market 47
- 3.3.2 RESTRAINTS AND THREATS 48
- 3.3.2.1 Requirement of large investment 48
- 3.3.2.2 Stringent safety and handling specifications associated with the production of
HPAPI 48
- 3.3.2.3 Stringent regulations 49
- 3.3.2.4 Alternative therapies to cure the cancer 50
- 3.3.1 DRIVERS AND OPPORTUNITIES 45
- 3.4.1 THREAT OF NEW ENTRANTS 52
- 3.4.2 THREAT OF SUBSTITUTES 53
- 3.4.3 RIVALRY AMONG EXISTING COMPETITORS 53
- 3.4.4 BARGAINING POWER OF BUYERS 54
- 3.4.5 BARGAINING POWER OF SUPPLIERS 54
- 3.5.1 U.S. 55
- 3.5.2 EUROPE 56
- 3.5.3 ASIA PACIFIC 57
- 3.5.4 REST OF THE WORLD 58
4 HPAPI GLOBAL MARKET, BY CUSTOMER BASE 72
- 4.1 INTRODUCTION 72
- 4.2 INNOVATIVE HPAPI 74
- 4.3 GENERIC HPAPI 75
5 HPAPI GLOBAL MARKET, BY BUSINESS TYPE 77
- 5.1 INTRODUCTION 77
- 5.2 CAPTIVE HPAPAI 78
- 5.3 MERCHANT HPAPI 80
6 HPAPI GLOBAL MARKET, BY MOLECULE TYPE 82
- 6.1 INTRODUCTION 82
- 6.2 SYNTHETIC HPAPIS 83
- 6.3 BIOTECH HPAPIS 85
7 HPAPI GLOBAL MARKET, BY APPLICATIONS 87
- 7.1 INTRODUCTION 87
- 7.2 CENTRAL NERVOUS SYSTEM DISORDERS 90
- 7.3 ONCOLOGY 92
- 7.4 HORMONAL DISORDERS 93
- 7.5 GLAUCOMA 95
- 7.6 INFECTIOUS DISEASES 96
- 7.7 METABOLIC DISORDERS 97
- 7.8 CARDIOVASCULAR 99
- 7.9 INFLAMMATION 100
- 7.10 OTHER THERAPEUTIC APPLICATIONS 101
8 REGIONAL MARKET ANALYSIS 103
- 8.1 INTRODUCTION 103
- 8.2 NORTH AMERICA 104
- 8.2.1 U.S. 110
- 8.2.2 OTHERS 114
- 8.3 EUROPE 116
- 8.3.1 SWITZERLAND 122
- 8.3.2 GERMANY 125
- 8.3.3 U.K. 128
- 8.3.4 OTHERS 131
- 8.4 ASIA PACIFIC 135
- 8.4.1 INDIA 141
- 8.4.2 CHINA 144
- 8.4.3 JAPAN 147
- 8.4.4 OTHERS 149
- 8.5 REST OF THE WORLD (ROW) 152
- 8.5.1 BRAZIL 157
- 8.5.2 REST OF LATIN AMERICA 159
- 8.5.3 MIDDLE EAST & OTHERS 161
9 COMPETITIVE LANDSCAPE 164
- 9.1 INTRODUCTION 164
10 . MAJOR COMPANIES 172
- 10.1 ALKERMES PLC 172
- 10.1.1 OVERVIEW 172
- 10.1.2 FINANCIALS 173
- 10.1.3 SERVICE PORTFOLIO 176
- 10.1.4 KEY DEVELOPMENTS 177
- 10.1.5 BUSINESS STRATEGY 177
- 10.1.6 SWOT ANALYSIS 178
- 10.2 CAMBREX CORPORATION 179
- 10.2.1 OVERVIEW 179
- 10.2.2 FINANCIALS 180
- 10.2.3 SERVICE PORTFOILIO 181
- 10.2.4 KEY DEVELOPMENTS 182
- 10.2.5 BUSINESS STRATEGY 182
- 10.2.6 SWOT ANALYSIS 183
- 10.3 DISHMAN GROUP 184
- 10.3.1 OVERVIEW 184
- 10.3.2 FINANCIALS 185
- 10.3.3 SERVICE PORTFOILIO 186
- 10.3.4 KEY DEVELOPMENTS 186
- 10.3.5 BUSINESS STRATEGY 186
- 10.3.6 SWOT ANALYSIS 187
- 10.4 DR. REDDY’S LABORATORIES 188
- 10.4.1 OVERVIEW 188
- 10.4.2 FINANCIALS 189
- 10.4.3 SERVICE PORTFOLIO 191
- 10.4.4 KEY DEVELOPMENTS 191
- 10.4.5 BUSINESS STRATEGY 191
- 10.4.6 SWOT ANALYSIS 192
- 10.5 LONZA GROUP 193
- 10.5.1 OVERVIEW 193
- 10.5.2 FINANCIALS 194
- 10.5.3 SERVICE PORTFOLIO 196
- 10.5.4 KEY DEVELOPMENTS 197
- 10.5.5 BUSINESS STRATEGY 197
- 10.5.6 SWOT ANALYSIS 198
- 10.6 NOVASEP 199
- 10.6.1 OVERVIEW 199
- 10.6.2 FINANCIALS 199
- 10.6.3 SERVICE PORTFOLIO 199
- 10.6.4 KEY DEVELOPMENTS 200
- 10.6.5 BUSINESS STRATEGY 200
- 10.6.6 SWOT ANALYSIS 201
- 10.7 PATHEON N.V.(THERMOFISHER SCIENTIFIC) 202
- 10.7.1 OVERVIEW 202
- 10.7.2 FINANCIALS 203
- 10.7.3 SERVICE PORTFOLIO 205
- 10.7.4 KEY DEVELOPMENTS 206
- 10.7.5 BUSINESS STARTEGY 207
- 10.7.6 SWOT ANALYSIS 208
- 10.8 PFIZER INC. 209
- 10.8.1 OVERVIEW 209
- 10.8.2 FINANCIALS 210
- 10.8.3 PRODUCT PORTFOLIO 212
- 10.8.4 SERVICE PORTFOLIO 212
- 10.8.5 KEY DEVELOPMENTS 212
- 10.8.6 BUSINESS STRATEGY 213
- 10.8.7 SWOT ANALYSIS 214
- 10.9 MERCK KGAA 215
- 10.9.1 OVERVIEW 215
- 10.9.2 FINANCIALS 216
- 10.9.3 PRODUCT PORTFOLIO 218
- 10.9.4 KEY DEVELOPMENTS 219
- 10.9.5 BUSINESS STRATEGY 219
- 10.9.6 SWOT ANALYSIS 220
- 10.10 TEVA PHARMACEUTICAL INDUSTRIES 221
- 10.10.1OVERVIEW 221
- 10.10.2FINANCIALS 221
- 10.10.3SERVICE PORTFOLIO 223
- 10.10.4KEY DEVELOPMENTS 223
- 10.10.5BUSINESS STRATEGY 224
Summary:
Get latest Market Research Reports on High Potency Active Pharmaceutical Ingredients (HPAPI). Industry analysis & Market Report on High Potency Active Pharmaceutical Ingredients (HPAPI) is a syndicated market report, published as High Potency Active Pharmaceutical Ingredients (HPAPI) Global Market – Forecast To 2023. It is complete Research Study and Industry Analysis of High Potency Active Pharmaceutical Ingredients (HPAPI) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
